Pakistan FSC Notarization and Embassy Attestation

1. Key takeaways

Medical device submissions in Pakistan require a Free Sale Certificate (FSC). The practical estimate is as follows: the FSC of the country of origin must be attested by the Pakistani embassy located in that country, and Class C and Class D devices additionally require the original FSC from a reference country, likewise attested by the embassy. The FSC must be within its validity period at the time of submission, and the product names and models stated on the certificate should match the scope of the intended registration exactly. Taken together, these conditions make the FSC one of the most scheduling-sensitive documents in the entire dossier: it is issued by an authority in another country, authenticated through a diplomatic channel, bound to a defined validity window, and held to a strict textual match against the registration scope. A delay or defect at any one of those four points propagates directly into the project timeline, which is why experienced teams manage the FSC as a tracked deliverable with owners, dates and fallback routes rather than as a certificate that is simply requested and received.

• An FSC is one of the documents required for imported device applications.
• The country-of-origin FSC must pass through Pakistani embassy attestation in the issuing country.
• Class C/D submissions need an additional original FSC from a reference country, also embassy-attested.
• Validity and consistency of the FSC must be re-checked before submission.
• The reference-country list is drawn from the reliance provision of the rules.
• Because attestation chains run through embassies, lead times must be planned into the master schedule, not discovered inside it.

2. Legal basis

The table below separates what the rules themselves state from what is the settled practical estimate of the market. The distinction matters when advising clients: statutory items cannot be negotiated, while practical items, though reliably expected, should be monitored for change.

3. Expert insights

Insight one: Pakistan is a market that demands double certification of the FSC. Class A and Class B submissions need only the certificate of the country of origin; Class C and Class D need two certificates, one from the country of origin and one from a reference country, and both must pass through embassy attestation. This brings the attestation cost and time of Class C/D projects close to double those of lower classes. The doubling is not only financial: each certificate moves on its own calendar, through its own issuing authority and its own embassy, and a slip in either chain delays the whole dossier. Planning Class C and D projects with a single attestation lane is therefore a structural error, not a scheduling detail.

Insight two: the attestation route must be judged country by country, and a blanket rule will fail. Pakistan has acceded to the Hague Apostille Convention (Apostille Ordinance 2024 / Apostille Act 2024), but Germany, the Czech Republic, Poland, Austria, Finland, the Netherlands, Denmark and Greece have raised objections to Pakistan’s accession, and the convention does not apply between Pakistan and those states. Several countries on the reference list, namely Germany, Austria, the Netherlands and Denmark, fall exactly inside this zone of objection — their FSCs must still travel the embassy attestation route. The practical lesson is that accession to a convention is a starting point for analysis, not the conclusion of it, and the objections register must be checked for every issuing state before an attestation route is committed.

Insight three: the consistency of the FSC matters more than its existence. The recurring practical failure is not a missing certificate but a mismatched one: the product names and models on the FSC do not correspond to the scope the applicant intends to register, so the eventual registration fails to cover the products it was meant to cover. Running a word-for-word comparison before submission is the lowest-cost risk control action available in this area. A mismatch discovered after submission costs a round of deficiency response; a mismatch discovered after grant costs an amendment cycle; the same mismatch discovered before submission costs a few minutes of careful reading.

4. Practical recommendations

• Manage the FSC as a two-countries, three-documents matter: first confirm whether the reference country appears on the Rule 15(2) list.
• Then confirm whether that country is one of the states objecting to Pakistan’s Hague convention accession; on that basis decide between the Apostille route and embassy attestation.
• Maintain a validity ledger for every FSC, and trigger a renewal reminder 12 months before expiry so a fresh certificate is always available.
• Renewal of the Pakistan registration requires a current FSC; an expired certificate stalls the renewal directly.
• Perform a word-for-word comparison of product names and models between the FSC and the intended registration scope before any submission.

5. Verification checklist

• □ Country-of-origin FSC notarized and attested by the Pakistani embassy
• □ Class C/D: original FSC from a reference country prepared and attested
• □ FSC product names and models verified word-for-word against the intended registration scope
• □ FSC validity recorded, with a reminder set 12 months before expiry
• □ Hague convention objection status judged country by country
• □ Completion date of the attestation chain checked against the project schedule

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Pakistan. Our team prepares dossiers to DRAP expectations, manages eCTD-format submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com